Press Releases
TNF Inhibitors Market to See Incredible Growth During 2025

TNF Inhibitors Market

, 3 January 2018 -- TNF Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the TNF levels remain steady. However, in a patient with rheumatoid arthritis, the level of TNF is increasing which leads to more inflammation. TNF inhibitor drugs act as blockers for TNF substances. TNF alpha blockers are highly effective in the treatment of patients with active rheumatoid arthritis. These drugs are used in patients as a conventional second-line treatments.

Report Overview @

Based on drug, the TNF inhibitors market can be segmented into etanercept, infliximab, adalimumab, certolizumab, and golimumab. The adalimumab segment is likely to expand at a significant pace during the forecast period. The drug is effectively used in a broad range of pain management therapies and is widely available over the counter. Based on distribution channel, the TNF inhibitors market can be segmented into hospital pharmacy and retail pharmacy. The hospital pharmacy segment is likely to expand at a significant pace between 2017 and 2025, this is because patients with rheumatoid arthritis, arthritis give more preference to the hospitals for treatment. Increase in elderly population and rise in the prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the factors that drive the TNF inhibitors market. According to the National Health Interview Survey, in 2016, almost 20% of the global population was reported to be suffering from chronic pain, with rheumatoid arthritis being one of the major reasons. Moreover, according to the Center for Disease Control and Prevention, by 2040, approximately 78 million (26%) of the U.S. ###### are projected to have arthritis. Owing to this, the consumption of TNF inhibitor dugs is likely to increase rapidly in the near future. However, side-effects associated with the use of TNF inhibitor drugs such as skin irritation, flushing, headache, and abdominal pain are estimated to hinder the market in the next few years.

Download Report Brochure @

In terms of region, the global TNF inhibitors market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market share, primarily due to favorable reimbursement policies for pain management prescription drugs in the region. Lenient regulations in Europe are playing a key role in the increased rate of development, approval, and commercialization of innovative molecule combinations in the pain management. This is likely to fuel the market in Europe during the forecast period. The increasing prevalent population and launching of new products are estimated to drive the market in Asia Pacific during the forecast period. Despite sustained growth and development Middle East & Africa had faced several health challenges over the last decade. Factors such as economic resources, adequate health care facilities, and growing burden of communicable diseases are likely to propel the market in the region from 2017 to 2025. Moreover, rheumatology services are limited or non-existent in several parts of sub-Saharan Africa. Hence, making these services available may boost the market in Middle East & Africa during the forecast period.

Major players operating in the global TNF inhibitors market are Pfizer, Boehringer Ingelheim, Novartis, Amgen, Mochida Pharmaceutical, Hanall, BioPharma, GalxoSmithKline, and Janssen Biotech.

Pre-Book Full Report @<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

# # #

Submitted by hawer on Wednesday, 3 January 2018 at 5:40 PM
Category: Health Care & Medical
Related News

Retail Clinics Market Comprehensive Analysis and Future Estimations 2024
Friday, 19 Jan 2018

Tuberculosis Drugs Market Trends with Forecast Upto 2025
Friday, 19 Jan 2018

How To Fall Asleep Naturally
Friday, 19 Jan 2018

Health Care Supply Chain Management Market Latest Trends and Forecast Analysis Upto 2024
Friday, 19 Jan 2018

Protein Drugs Market Opportunity Analysis and Industry Forecast Upto 2019
Friday, 19 Jan 2018

Related Events

EDGE Endourology & Enucleation Symposium 2018, Scottsdale, Arizona
Friday, 19 Jan 2018

2018 Progress and Controversies in Gynecologic Oncology Conference
Friday, 19 Jan 2018

Mayo Clinic Cardiology Update at Cabo: A Focus on Prevention
Monday, 22 Jan 2018

Social Media in the Pharmaceutical Industry
Monday, 22 Jan 2018

Real-Time Benefit Verification and Electronic Prior Authorization Forum
Monday, 22 Jan 2018

Latest News

Trying to grow your business? Think about updating your merchant processing!
Friday, 19 Jan 2018

Using CSS Transitions - SlideUp and SlideDown
Friday, 19 Jan 2018

Chic ways to deck up the fabric sofa in your living
Friday, 19 Jan 2018

How To Prepare A Set Of String Lights For Totally New Season
Friday, 19 Jan 2018

Why you should pick a better mobile credit card reader for your business
Friday, 19 Jan 2018

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Friday, 19 January 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Light to Night Festival
  • EDGE Endourology & Enucleation Symposium 2018, Scottsdale, Arizona
  • Mexico Caribbean Adventure
  • 2018 Progress and Controversies in Gynecologic Oncology Conference
  • London Blockchain Week 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.